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Abstract
Factorial designs are widely used in agriculture, engineering, and the social sciences to study
the causal effects of several factors simultaneously on a response. The objective of such a
design is to estimate all factorial effects of interest, which typically include main effects and
interactions among factors. To estimate factorial effects with high precision when a large
number of pre-treatment covariates are present, balance among covariates across treatment
groups should be ensured. We propose utilizing rerandomization to ensure covariate bal-
ance in factorial designs. Although both factorial designs and rerandomization have been
discussed before, the combination has not. Here, theoretical properties of rerandomization
for factorial designs are established, and empirical results are explored using an application
from the New York Department of Education.
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1. INTRODUCTION
2K factorial designs involve K factors each with two levels, often denoted as the “high
level” and “low level” of the factor (Yates 1937, Fisher 1942). With K factors, there are
2K unique treatment combinations to which units can be assigned, and often the same
number of units are assigned to each combination. Factorial designs are often discussed
in an industrial setting, where units are essentially identical and the assignment of units
to treatments is arbitrary. However, in recent years factorial designs have become more
prevelant in clinical trials and the social sciences, where pre-treatment covariates are available
and reveal that units differ. For example, the New York Department of Education (NYDE)
had five “incentive programs” to introduce to high schools, and it wanted to estimate the
effect of these programs and their combinations on schools’ performance. Given 50 pre-
treatment covariates for each of the 1,376 schools, how should the department allocate the
schools to the 32 different treatment combinations of the design such that the effects of the
incentive programs and their combinations are well-estimated?
An initial idea for this example is to randomize the schools to the 32 treatment combina-
tions. Randomized experiments are considered the “gold standard” because randomization
balances all potential confounders on average (Krause and Howard 2003, Morgan and Rubin
2012). However, many have noted that randomized experiments can yield “bad allocations,”
where some covariates are not well-balanced across treatment groups (Seidenfeld 1981, Lind-
ley 1982, Papineau 1994, and Rosenberger and Sverdlov 2008). Covariate imbalance among
different treatment groups complicates the interpretation of estimated treatment effects.
If “bad allocations” are a concern for treatment-versus-control experiments, they are
even more of a concern for factorial designs, because any randomization may create covariate
imbalance across some of the 2K treatment combinations. This point has been given little
attention in the literature. Classic experimental design textbooks like Box, Hunter, and
Hunter (2005) and Wu and Hamada (2009) suggest using blocking to balance important
covariates; however, the use of blocking is not obvious with many covariates, some with
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many levels. Additionally, Wu and Hamada (2009) note that blocking can increase precision
for some factorial effect estimators and “sacrifice” the precision of other factorial effect
estimators. To address this issue, we propose a rerandomization algorithm for balanced
2K factorial designs based on Morgan and Rubin (2012), which developed a framework for
rerandomization in the treatment-versus-control case. Here we establish several theoretical
properties of rerandomization in balanced 2K factorial designs that increase the precision of
factorial effect estimators.
Both rerandomization and factorial designs have been explored since Fisher in the 1920s.
To our knowledge, however, no one has laid out the framework for implementing rerandom-
ization for factorial designs. Rubin (2008) noted that many did not implement rerandomiza-
tion because it was computationally intensive; however, with recent improvements in com-
putational power, some have revisited rerandomization. For example, Cox (2009), Bruhn
and McKenzie (2009), and Worrall (2010) all discuss and recommend rerandomization, and
Morgan and Rubin (2012) formalized these recommendations in treatment-versus-control
settings.
Also, often there are few pre-experiment covariates to consider in a factorial design, or
they are categorical - such as the “batch” of units produced, as described in Box, Hunter,
and Hunter (2005) - and thus simple blocking is an appropriate strategy. In contrast, Wald,
et al. (1991), Apfel, et al. (2002), and Bays et, al. (2004) all describe clinical trials
that utilized randomized factorial designs with non-categorical covariates, which could have
benefited from a design that ensured covariate balance. To illustrate how rerandomization
can be utilized in such situations, we use an education example discussed in Dasgupta, et
al. (2015).
Our proposed rerandomization algorithm is not the first procedure that attempts to
balance non-categorical covariates for experiments with multiple treatments. The Finite Se-
lection Model (FSM) developed by Morris (1979) assigns units to multiple treatment groups
such that covariates are relatively balanced among the groups. Morgan and Rubin (2012)
noted that rerandomization and the FSM both attempt to ensure covariate balance, but the
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FSM does not maintain the correlation structure among covariates, whereas rerandomization
can.
Xu and Kalbfleisch (2013) proposed the “balance match weighted design” for multiple
treatment groups, which performs many randomizations and then selects the randomization
that yields the best covariate balance. This is similar to rerandomization, but rerandom-
ization’s theoretical guarantees, such as balancing on unobserved covariates on average in
addition to improving balance for observed covariates, is appealing. Our rerandomization
algorithm can also incorporate various desiderata, such as factorial effects and covariates
that vary in importance, which makes the procedure particularly flexible.
In Section 2 we review rerandomization for the treatment-versus-control case, and in
Section 3 we establish notation for 2K factorial designs using the potential outcomes frame-
work. In Section 4 we outline the proposed rerandomization procedure, and in Section 5
we establish theoretical properties that formalize the ways rerandomization is preferable to
standard randomization. In Section 6 we use our rerandomization procedure on data from
the NYDE.
2. REVIEW OF RERANDOMIZATION
Rubin (2008) recalled a conversation with Bill Cochran, who in turn recalled a conversation
with R.A. Fisher, who asserted that a way to protect ourselves against particularly bad
randomizations is to rerandomize until a randomization is “acceptable.” Morgan and Rubin
(2012) suggested implementing rerandomization for a treatment-versus-control experiment
as follows:
1. Collect covariate data.
2. Specify a balance criterion determining when a randomization is acceptable.
3. Randomize units to treatment and control groups.
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4. Check the balance criterion. If the criterion is met, go to Step 5. Otherwise, return to
Step 3.
5. Conduct the experiment using the final randomization obtained in Step 4.
6. Analyze the results using a randomization test, keeping only simulated randomizations
that satisfy the balance criteria specified in Step 2.
Morgan and Rubin (2012) used the squared Mahalanobis distance (Mahalanobis 1936)
as a measure for covariate balance. With n units, half assigned to treatment and half assigned
to control, and p observed covariates for each unit, the squared Mahalanobis distance for the
treatment-versus-control situation is defined as:
M ≡ (x¯T − x¯C)T cov[(x¯T − x¯C)]−1(x¯T − x¯C),
where x¯T is the p-component column vector of covariate means for units assigned to the
treatment and x¯C is analogously defined for the control. A randomization is declared ac-
ceptable if M ≤ a for some threshold a. The Mahalanobis distance is well-known within the
matching and observational study literature, where it is used to find subsets of the treatment
and control that are similar (Rubin 1976, Rosenbaum and Rubin 1985, Gu and Rosenbaum
1993, Rubin and Thomas 2000). Constraining M ≤ a can be viewed as finding allocations
where the treatment and control covariate means are “similar enough,” where the “enough”
is determined by the threshold a. Morgan and Rubin (2012) note that - similar to Rosen-
baum and Rubin’s (1985) argument that matching using the Mahalanobis distance reduces
bias due to imbalances in covariates from observational studies - rerandomization using M
reduces the sampling variance of the standard treatment effect estimator when outcome
variables are correlated with covariates.
Morgan and Rubin (2012) showed that M closely follows a chi-squared distribution with
degrees of freedom equal to p. Thus, a can be selected by first deciding the percentage, pa,
of randomizations that will be “acceptably well-balanced,” and then setting a to the path
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percentile of the χ2p distribution. For example, if there are five covariates, and we want to
select from the 1% “most balanced” randomizations, then a is set equal to the first percentile
of the χ25 distribution.
Morgan and Rubin (2012) mention two options for balancing covariates among multiple
treatment groups:
1. Create a criterion for each pairwise comparison among the treatment groups, and then
rerandomize if any group does not satisfy the criterion.
2. Use a statistic that measures multivariate balance, such as those used in standard
MANOVA analyses.
To implement (1), a criterion for each (2K2 ) = 2K−1(2K − 1) pairwise comparison must be
chosen, which may be computationally burdensome. To implement (2), there must be a
notion of “within-group” variance, which is not immediate for unreplicated 2K factorial
designs where only one unit is assigned to each treatment combination. Furthermore, we
may not want to estimate all factorial effects with the same level of precision; for instance,
typically we want to estimate main effects more precisely than high-order interactions, and
it is not clear how to incorporate this desideratum into (1) or (2). We propose an intuitive
adjustment to (1) for balanced 2K factorial designs, which is equivalent to (2) for replicated
factorial designs. The proposed adjustment also allows hierarchies of effect importance.
3. NOTATION FOR 2K DESIGNS UNDER THE POTENTIAL
OUTCOMES FRAMEWORK
Consider a balanced 2K factorial design with n = r2K units and r replicates assigned to each
of the 2K treatment combinations. In a 2K factorial design there are 2K − 1 factorial effects:
K main effects, (K2 ) two-way interactions, (K3 ) three-way interactions, and so on.
The 2K treatment combinations of a 2K factorial design are often arranged in a specific
order and represented as a 2K ×K matrix whose elements are either -1 (representing the
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Table 1: The Design Matrix, G, for a 23 design
A B C
-1 -1 -1
-1 -1 +1
-1 +1 -1
-1 +1 +1
+1 -1 -1
+1 -1 +1
+1 +1 -1
+1 +1 +1
Table 2: G̃ for a 23 design (columns 2-4 represent the design matrix G)
Mean Column Main effect columns Interaction columns
A B C AB AC BC ABC
+1 -1 -1 -1 +1 +1 +1 -1
+1 -1 -1 +1 +1 -1 -1 +1
+1 -1 +1 -1 -1 +1 -1 +1
+1 -1 +1 +1 -1 -1 +1 -1
+1 +1 -1 -1 -1 -1 +1 +1
+1 +1 -1 +1 -1 +1 -1 -1
+1 +1 +1 -1 +1 -1 -1 -1
+1 +1 +1 +1 +1 +1 +1 +1
“low level” of a factor) or +1 (representing the “high level” of a factor), and thus each
row indicates a unique combination of factor assignments. This matrix is often referred to
as the design matrix (Wu and Hamada 2009). One such order for the -1s and +1s is the
lexicographic order (Espinosa, et al. 2015) in which each column starts with −1, making the
first row of the matrix a K-component vector of -1s. In the first column, the sign is switched
to +1 for the second half (i.e., 2K−1) of the components. In the second column, the sign is
switched after every one-fourth (i.e., 2K−2) of the components. Proceeding this way, the last
column consists of alternating -1s and +1s. We denote the design matrix by G; see Table 1
for a 23 factorial design using the lexicographic order. Another well-known order is Yates’
order, in which the columns appear in exactly the reverse order of the lexicographic order.
To define the interaction effects, we expandG (the columns labeled “main effect columns”
in Table 2) by augmenting its columns. The column for a specific interaction is created using
component-wise multiplication of the corresponding main-effects columns. For example, the
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Table 3: Unit-level and Population-Level Factorial Effects for a 23 Design
Unit (i) Potential outcomes (Yi) Mean of unit i (θi0) Factorial effect θi,f
1 Y1 = (Y1(1),⋯, Y1(8)) 8−1Y1G̃.0 4−1Y1G̃.f
2 Y2 = (Y2(1),⋯, Y2(8)) 8−1Y2G̃.0 4−1Y2G̃.f⋮ ⋮ ⋮ ⋮
n Yn = (Yn(1),⋯, Yn(8)) 8−1YnG̃.0 4−1YnG̃.f
Average Y¯ = n−1 (∑i Yi(1),⋯,∑i Yi(8)) 8−1Y¯ G̃.0 θ¯f = 4−1Y¯ G̃.f
last column in Table 2 represents the three-way interaction among factors A, B and C, and
is obtained by multiplying the components in the three columns of G. Having appended
the interaction columns to the right of G (columns 5-8 of Table 2) to define the interaction
effects, a column of +1s is appended to the left of G (first column of Table 2) which defines
the mean effect. The result is a 2K×2K matrix, denoted by G̃. The rows of G̃ are indexed by
j = 1, . . . ,2K , one row for each treatment combination, as indicated by G, and the columns
are indexed by f = 0,1, . . . ,2K − 1; “f” for factorial effects. Let G̃j. and G̃.f denote the jth
row and fth column of G̃, respectively.
Let Yi(j), i = 1, . . . , n, j = 1, . . . ,2K denote the potential outcome for the ith unit when
exposed to the jth treatment combination, and let Yi = (Yi(1), . . . , Yi(2K)) denote the row
vector of the 2K potential outcomes for unit i. The ith row of the left part of Table 3 shows
Yi for a 23 design.
Following Dasgupta, et al. (2015), the fth linear factorial effect for unit i is:
θif = 1
2K−1YiG̃.f , i = 1, . . . , n, f = 1, . . . ,2K − 1
and the population-level fth factorial-effect is defined as:
θ¯f = 1
n
n∑
i=1 θif . (1)
The fth factorial effect at the unit level and the population level, represented as functions of
the potential outcomes, are shown in the last column of Table 3. The second-to-last column
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of Table 3 shows the unit-level mean of the potential outcomes
θi0 = 1
2K
YiG̃.0
and their grand mean θ¯0. The population-level grand mean θ¯0 and the linear factorial effects
θ¯1, . . . , θ¯2K−1 are the estimands (objects of interest) in the standard linear finite-population
framework described here. They need to be estimated because only one element of Yi can
be observed for each i. We discuss unbiased estimators of these estimands in Section 4.
The vector (θi0, . . . , θi(2K−1)) of estimands for unit i is a linear transformation of the
vector Yi of potential outcomes. Letting the factorial effects vector for unit i be
θi = (θi0, θi1
2
, . . . ,
θi(2K−1)
2
) , i = 1, . . . , n, (2)
straightforward algebra shows that the potential outcomes for unit i can be written as
Yi = θi.G̃T
so the jth component of Yi is
Yi(j) = θiG̃Tj., (3)
4. THE ASSIGNMENT MECHANISM, UNBIASED
ESTIMATION OF FACTORIAL EFFECTS, AND THE
RERANDOMIZATION ALGORITHM
Randomized balanced 2K factorial designs assign n = r2K units to one of 2K treatment
combinations with equal probability such that r units are assigned to each combination.
Each combination corresponds to a row of the design matrix G. Let W be a n×K random
matrix where the ith row of W , Wi., indicates the treatment assignment for unit i, and has
probability 1
2K
of being the jth row of G: P (Wi. = Gj.) = 12K for i = 1, . . . , n, j = 1, . . . ,2K .
9
For notational convenience, we expand W to W̃ such that P (W̃i. = G̃j.) = 12K , where the
first column of W̃ , W̃.0, is not stochastic and is +1s, as in G̃; every other element of W̃ for
i = 1, . . . , n and f ∈ F ≡ {1, . . . ,2K − 1} is defined as
W̃if =
⎧⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎩
+1 if the ith unit is assigned to high level of f
−1 if the ith unit is assigned to low level of f (4)
Let W̃.f be the n x 1 column vector denoting the assigned level of some f ∈ F for all units.
A particular random allocation of units in a 2K design corresponds to one realization of
W̃ , the observed one, W̃ obs. The observed outcome for the ith unit will be the potential
outcome Yi(j) when W̃ obsi. = G̃j.. Let yobs be the n-component column vector of observed
outcomes for the n units. The standard estimator of the factorial effect θ¯f defined in (1) can
be written in terms of the observed outcomes and W̃ :
θˆf = y¯f+ − y¯f− = yTobsW̃.f
n/2 (5)
where y¯f+ is the mean outcome for units assigned to the high level of some f ∈ F , and y¯f− is
analogously defined for the low level of f .
Rerandomization involves randomizing until an allocation is declared “acceptable,” us-
ing an acceptance criterion φ(X,W̃ ), where X is the n × p covariate matrix, and φ equals
one if an allocation is “acceptable” and zero otherwise.
Consider an acceptance criterion that is symmetric in W̃ , i.e., a φ such that φ(X,W̃ ) =
φ(X,−W̃ ). Theorem 1 below establishes that the standard factorial effect estimators are
unbiased under any rerandomization scheme that uses a symmetric acceptance criterion.
Theorem 1: Suppose a completely randomized balanced 2K factorial design is rerandomized
when φ(X,W̃ ) = 0 for some symmetric acceptance criterion. Then, for all f ∈ F ,
E[θˆf ∣φ(X,W̃ ) = 1] = θ¯f ,
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where θˆf is the estimator defined in (5) and θ¯f is the population-level estimand defined in (1).
Because φ is symmetric in W̃ , the proof of the unbiasedness of θˆf under rerandomization is
analogous to that in Morgan and Rubin (2012) for the treatment-versus-control situation.
If the potential outcomes are correlated with pre-experiment covariates, then so will
be the observed outcomes and the estimator θˆf for any f ∈ F . Intuitively, we can increase
the precision of θˆf by ensuring covariates are “well-balanced” over the two groups used to
calculate θˆf : the “treatment” (units assigned to the high level of f) and the “control” (units
assigned to the low level), which suggests a balance function that measures the covariate
balance between all pairs of these groups.
One such balance function is the squared Mahalanobis distance proposed by Morgan
and Rubin (2012). A way to measure the covariate balance between the “treatment” and
“control” for a particular f is to define
Mf ≡ (x¯f+ − x¯f−)T cov[(x¯f+ − x¯f−)]−1(x¯f+ − x¯f−)
= n
4
(x¯f+ − x¯f−)T cov[X]−1(x¯f+ − x¯f−) (6)
where x¯f+ is the p-component vector of covariate means for units assigned to the high level
of f and x¯f− is analogously defined. Note that, analogous to (5), x¯f+ − x¯f− = XT W̃.fn/2 .
The covariate balance between the “treatment” and the “control” for a particular f is
declared “acceptable” by the acceptance criterion
φf(X,W̃ ) =
⎧⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎩
1 if Mf ≤ a
0 if Mf > a (7)
for a predetermined threshold a. An intuitive procedure that parallels Morgan and Rubin
(2012) is to randomize until φf(X,W̃ ) = 1 in order to increase the covariate balance between
the “treatment” and “control” for a particular f . We can do this for every f ∈ F , and thereby
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define the overall acceptance criterion as
φ(X,W̃ ) =∏
f∈F φf(X,W̃ ) =
⎧⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎩
1 if maxf∈F Mf ≤ a
0 if maxf∈F Mf > a (8)
We thus propose the following rerandomization procedure for balanced 2K factorial designs:
1. Create a squared Mahalanobis distance criterion Mf for each f ∈ F .
2. Choose a threshold criterion a as in Morgan and Rubin (2012).
3. Randomize until φ(X,W̃ ) = 1, where φ is defined as in (8).
We have the following corollary:
Corollary 1: Theorem 1 holds if φ(X,W̃ ) is defined as in (8).
Section 5 establishes that the above rerandomization algorithm increases the precision
of all factorial effect estimators compared to pure randomization.
5. PRECISION PROPERTIES OF RERANDOMIZATION
The proposed rerandomization algorithm checks Mf for all f ∈ F , i.e., φ(X,W̃ ) = 1 iff
φf(X,W̃ ) = 1 for all f ∈ F . Thus, both the marginal and joint distributions of {x¯f+ − x¯f− ∶
f ∈ F} and {θˆf ∶ f ∈ F} need to be examined.
Theorem 2: Assume a completely randomized balanced 2K factorial design is rerandomized
using the algorithm proposed at the end of Section 4. Then,
E[xf+ −xf− ∣φ(X,W̃ ) = 1] = 0
The proof of Theorem 2 follows immediately by symmetry of the acceptance criterion, as in
Morgan and Rubin (2012).
Lemma 1: Assume a completely randomized balanced 2K factorial design is rerandomized
using the algorithm proposed at the end of Section 4, and the covariate means are mul-
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tivariate normal. Then, the elements of {φf(X,W̃ ) ∶ f ∈ F} defined in (7) are mutually
independent.
The proof of Lemma 1 is in the Appendix.
Theorem 3: Assume a completely randomized balanced 2K factorial design is rerandom-
ized using the algorithm proposed at the end of Section 4, and the covariate means are
multivariate normal. Then:
First, for all f ∈ F ,
cov[xf+ −xf− ∣φ(X,W̃ ) = 1] = vacov[xf+ −xf−]
where
va = 2
p
γ(p2 + 1, a2)
γ(p2 , a2) , (9)
and γ is the incomplete gamma function γ(b, c) ≡ ∫ c0 yb−1e−ydy.
And second, for f1, f2 ∈ F, f1 ≠ f2,
cov[xf+1 −xf−1 ,xf+2 −xf−2 ∣φ(X,W̃ ) = 1] = 0
Theorem 3 is proved in the Appendix.
Theorems 2 and 3 establish that rerandomization leads to unbiased estimators and
reduces the variance of (x¯f+ − x¯f−), and that this reduction is the same for all covariates.
We define the percent reduction in variance for any covariate p and f ∈ F as:
100(var[x¯p,f+ − x¯p,f−] − var[xp,f+ − x¯p,f− ∣φ(X,W̃ ) = 1]
var[x¯p,f+ − x¯p,f−] ) = 100(1 − va) (10)
Therefore, for any covariate p and f ∈ F , the rerandomization algorithm will reduce the
variance of (x¯p,f+ − x¯p,f−) in expectation by 100(1 − va)%, compared to pure randomization.
To state properties of the marginal and joint distributions of the factorial effect estima-
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tors {θˆf ∶ f ∈ F}, assumptions must be made about the relationship between the potential
outcomes and the factorial effects and covariates. Suppose the factorial effects θi defined
in (2) are constant across units and there is no interaction between factorial effects and
covariate effects. Then, the potential outcomes can be written using the following linear
model:
Yi(j) = θiG̃Tj. +xiβ + i, i = 1, . . . , n, j = 1, . . . ,2K (11)
where G̃j. is the jth row of G̃ defined in Section 3, β is the p-component column vector of
fixed covariate coefficients, and i indicates any deviations from the linear model. Then, the
standard unbiased estimator (5) can be written as:
θˆf = θ¯f +βT (x¯f+ − x¯f−) + (¯f+ − ¯f−) (12)
and the theorem below follows.
Theorem 4: Assume (a) a completely randomized balanced 2K factorial design is reran-
domized using the algorithm proposed at the end of Section 4, (b) the covariate means
are multivariate normal, (c) factorial effects are constant across units, and (d) there is no
interaction between factorial effects and covariate effects. Then, for all f ∈ F ,
var(θˆf ∣φ(X,W̃ ) = 1) = (1 − (1 − va)R2)var(θˆf) (13)
and for f1, f2 ∈ F , such that f1 ≠ f2,
cov(θˆf1 , θˆf2 ∣φ(X,W̃ ) = 1) = 0
where R2 is the squared multiple correlation coefficient between yobs and X, and va is defined
in (9). The proof of Theorem 4 is in the Appendix.
Theorem 4 has several implications. First, randomizing until Mf ≤ a for all f ∈ F
on average increases the precision of all factorial effect estimators equally by 100(1 − va)R2
percent. Likewise, for some subset F ∗ ⊂ F , randomizing until Mf ≤ a equally increases
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the precision of θˆf for all f ∈ F ∗, again by 100(1 − va)R2 percent, but this does not affect
the precision of θˆf for any f ∉ F ∗, by the uncorrelated result of Theorem 4. Furthermore,
different thresholds can be chosen for each squared Mahalanobis distance criterion. For
example, one can randomize until Mf ≤ af , where af differs across f . Choosing a smaller af
for each f ∈ F ∗ ensures a higher increase in precision for the corresponding factorial effect
estimator θˆf .
Thus, we can adapt our rerandomization procedure according to tiers of importance for
factorial effects. Furthermore, we can do the same for covariates, analogous to Morgan and
Rubin (2015), which shows how to adapt rerandomization according to tiers of importance
for covariates in the treatment-versus-control case.
To conduct inference using rerandomization, the significance levels of hypotheses should
be calculated using a permutation test (Fisher 1942). However, during the permutation
test, the distribution of the test statistic under Fisher’s sharp null must be created using
randomizations that would be accepted under rerandomization (Morgan and Rubin 2012).
Corrections for multiple testing and selection of active versus inactive effects (as in Espinosa,
et al. 2015) are topics for future work.
Theorems 3 and 4 require n to be sufficiently large such that the covariate means are
multivariate normal. If the covariate means are multivariate normal, then the Mahalanobis
distance is χ2p (Mardia et al. 1980). However, if n is not large enough for the normality
assumption to hold via the Central Limit Theorem, then (a) the Mahalanobis distance will
not be χ2p, and (b) the independence in Lemma 1 will not hold. To address (a), the empirical
distribution of eachMf can be used instead of the χ2p distribution to select each corresponding
threshold af . As for (b), the elements of {x¯f+ − x¯f− ∶ f ∈ F} (and, as a consequence, the
elements of {Mf ∶ f ∈ F}) are always uncorrelated under our proposed rerandomization
algorithm. This implies that, under mild regularity conditions, rerandomization will still
increase the precision of factorial effect estimators; however, theoretical results found in
Theorems 3 and 4 will not hold exactly.
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6. ILLUSTRATING RERANDOMIZATION IN A 25
EDUCATION EXAMPLE
Dasgupta, et al. (2015) discuss an educational experiment planned by the New York De-
partment of Education (NYDE) with five “incentive programs” to be introduced to high
schools “which desperately need performance improvement.” The programs include a qual-
ity review, a periodic assessment, inquiry teams, a school-wide performance bonus program,
and an online-resource program (Dasgupta, et al. 2015).
The NYDE measures schools’ performance with a score in each school’s Progress Report,
and we consider nine covariates that will likely be correlated with this score: Total number
of students, five different race variables (proportion of white, black, Asian, Native American,
and Latino students), proportion of female students, enrollment rate, and poverty rate. This
situation can be considered an extreme case of a “tiers of covariates” framework, where a
subset of nine covariates are considered “important” and the rest are considered “not im-
portant.” The goal is to assign 43 schools to each of the 32 different treatment combinations
such that the factorial effects of the experiment will be well-estimated.
Interest usually focuses on main effects and possibly two-way interactions, and higher-
order interactions are often considered negligible (Wu and Hamada 2009). Thus, we imple-
ment a rerandomization algorithm that considers main effects “most important,” two-way
interactions “less important,” and higher-order interactions “not important.” We created
fifteen squared Mahalanobis distances: one for each of the five main effects and ten two-way
interactions. The rerandomization algorithm involves randomizing until max(M1, . . . ,M5) ≤
amain and max(M6, . . . ,M15) ≤ ainteraction, where amain is the 100(0.011/5) percentile of the χ29
distribution so P (M1, . . . ,M5 ≤ amain) = 1%, because, according to Lemma 1, the squared
Mahalanobis distances are independent (and approximately χ29). Similarly, ainteraction is the
100(0.11/10)% percentile of the χ29 distribution, making the criterion corresponding to the
interaction effects less stringent than that of the main effects.
We performed pure randomization and rerandomization 1,000 times. For each (re)randomization,
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the covariate mean difference (x¯p,f+ − x¯p,f−) was calculated for each covariate p and fac-
tor/interaction f . Figure 1 displays the empirical percent reduction in variance, which
shows how much rerandomization reduced the variance of the covariate mean difference for
various covariates and factors/interactions compared to pure randomization. Main effects
are marked with circles, two-way interaction effects with squares, and three-way interaction
effects with triangles. The percent reduction in variance expected given Theorem 3 is marked
by a vertical line for each type of factorial effect.
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black
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Figure 1: Percent reduction in variance in the covariate mean difference after rerandomization
for various covariates and factorial effects. The expected percent reduction in variance given
Theorem 3 for each type of factorial effect is marked by a vertical line. Displayed are the nine
covariates considered during rerandomization as well as “number of teachers” and “number
of students in temporary housing,” which were not considered.
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The nine covariates we considered during rerandomization are displayed at the top
of the vertical axis of Figure 1. Rerandomization reduced the variance of the covariate
mean difference across factors and two-way interactions compared to pure randomization
for these covariates, and the reduction varies around what we would expect given Theorem
3. There is more reduction for individual factors than for interactions, as is expected,
because the threshold amain was more stringent than ainteraction. The percent reduction in
variance across three-way interactions is occassionally negative - implying randomization
yielded better covariate balance in this case - but this reduction averages close to zero, as
expected. Therefore, rerandomization on average increased the covariate balance across main
effects and two-way interactions without sacrificing the covariate balance across higher-order
interactions. Although one may be concerned about some fairly negative values for three-
way interactions - there are two percent reduction in variances below -19% - this behavior
is similar to what would happen if we instead compared 1,000 randomizations to 1,000
different randomizations. On average, rerandomization was equivalent to randomization in
terms of three-way interactions, which is expected, because three-way interactions were not
considered during rerandomization.
Figure 1 also displays the percent reduction in variance for two covariates not consid-
ered during rerandomization: “number of teachers” and “number of students in temporary
housing.” Rerandomization yielded more balance for “number of teachers” compared to
pure randomization, because “number of teachers” is highly correlated (R2 = 0.95) with
“number of students,” which was considered during rerandomization. Likewise, “number of
students in temporary housing” was only mildly correlated with the covariates considered
during rerandomization, and thus it did not benefit greatly from rerandomization. If the
NYDE decided that these two covariates were important to balance, but less so than the
nine covariates already considered, we could rerandomize efficiently by balancing only the
functions of “number of teachers” and “number of students in temporary housing” that are
orthogonal to the nine “most important” covariates, because the parts that are correlated
will already be balanced.
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If outcome variables of the NYDE experiment are correlated with these covariates, then
rerandomization will yield more precise estimates of the main factorial effects and two-way
interactions. Furthermore, the precision of higher-order factorial effects will not be worse
compared to pure randomization.
7. CONCLUSION
Rerandomization is known to increase the precision of the treatment effect estimator for
treatment-versus-control experiments (Morgan and Rubin 2012). Here, rerandomization has
been explored for balanced 2K factorial designs. Theoretical results under common assump-
tions show that rerandomization yields unbiased estimators and increases the precision of
factorial effect estimators of interest without sacrificing the precision of other estimators.
Empirical results illustrate these theoretical results via a real-data application. The reran-
domization algorithm can also be adjusted so tiers of importance for covariates and factorial
effects can be incorporated. Extensions for more complex designs - such as unbalanced
designs and fractional factorial designs - will be future work.
8. APPENDIX
Proof of Lemma 1
Assume a completely randomized balanced 2K factorial design is rerandomized using the
algorithm proposed at the end of Section 4, and the covariate means are multivariate nor-
mal. Under both randomization and rerandomization, the columns of W̃ defined in (4) are
orthogonal. Because the factorial design is balanced and the criterion function φ defined in
(8) is symmetric in W̃ , E[W̃.f ∣φ(X,W̃ ) = 1] = 0 for all f ∈ F . Therefore, for any f1, f2 ∈ F ,
cov(W̃f1 ,W̃f2 ∣φ(X,W̃ ) = 1) = 0.
Therefore, Cov(W̃ ∣φ(X,W̃ ) = 1) is a block-diagonal matrix. Because x¯f+−x¯f− = XT W̃.fn/2 ,
the covariance matrix of the elements of {x¯f+ − x¯f− ∶ f ∈ F} is block-diagonal under reran-
domization. By assumption the covariate means are multivariate normal, and thus this
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block-diagonal covariance matrix implies the elements of {x¯f+ − x¯f− ∶ f ∈ F} are mutually
independent under rerandomization. Additionally, the elements of {Mf ∶ f ∈ F} are mutu-
ally independent, because every Mf is a function of x¯f+ − x¯f− . Similarly, the elements of{φf(X,W̃ ) ∶ f ∈ F} are mutually independent, where φf(X,W̃ ) is defined in (7). ◻
Proof of Theorem 3
Assume a completely randomized balanced 2K factorial design is rerandomized using the
algorithm proposed at the end of Section 4, and the covariate means are multivariate normal.
The elements of {φf(X,W̃ ) ∶ f ∈ F} are mutually independent given Lemma 1. Therefore,
E[xf+ −xf− ∣φ(X,W̃ ) = 1] = E[xf+ −xf− ∣φf(X,W̃ ) = 1]
= E[xf+ −xf− ∣Mf ≤ a]
where φ(X,W̃ ) is defined in (8). Similarly, for f1 = f2,
cov[xf+1 −xf−1 ,xf+2 −xf−2 ∣φ(X,W̃ ) = 1] = cov[xf+1 −xf−1 ,xf+2 −xf−2 ∣φf(X,W̃ ) = 1]= cov[xf+1 −xf−1 ,xf+2 −xf−2 ∣Mf ≤ a]
while for f1 ≠ f2,
cov[xf+1 −xf−1 ,xf+2 −xf−2 ∣φ(X,W̃ ) = 1] = 0
because the elements of {x¯f+ − x¯f− ∶ f ∈ F} are mutually independent. The remainder of
the proof is identical to the treatment-versus-control case, where the units assigned to the
high level of f are the “treatment” and the units assigned to the low level are the “control.”
Thus, analogous to Morgan and Rubin (2012), for f1 = f2,
cov[xf+1 −xf−1 ,xf+2 −xf−2 ∣Mf ≤ a] = vacov[xf+1 −xf−1 ,xf+2 −xf−2 ]
where va is defined as in (10). ◻
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Proof of Theorem 4
Assume (a) a completely randomized balanced 2K factorial design is rerandomized using
the algorithm proposed at the end of Section 4, (b) the covariate means are multivariate
normal, (c) factorial effects are constant across units, and (d) there is no interaction between
factorial effects and covariate effects. Because the factorial effects are constant across units,
each factorial effect estimator θˆf can be written as (12). By Lemma 1, for f1 ≠ f2, cov(xf+1 −
xf−1 ,xf+2 − xf−2 ∣φ(X,W̃ ) = 1) = 0. Furthermore, the difference of the covariate means is
orthogonal to the difference of the residual means, and therefore the covariance between
them is zero. Therefore,
cov(θˆf1 , θˆf2 ∣φ(X,W̃ ) = 1) = cov[(¯f+1 − ¯f−1 ), (¯f+2 − ¯f−2 )∣φ(X,W̃ ) = 1] = 0
The final equality holds because, by the balance of the design, under both randomization
and rerandomization,
cov(¯f+1 , ¯f+2 ) = cov(¯f+1 , ¯f−2 ) = cov(¯f−1 , ¯f+2 ) = cov(¯f−1 , ¯f−2 )
and thus the covariance between any two factorial effect estimators under rerandomization
is zero. Furthermore, for all f ∈ F ,
var(θˆf ∣φ(X,W̃ ) = 1) = βT cov(x¯f+ − x¯f− ∣φ(X,W̃ ) = 1)β + var(¯f+ − ¯f− ∣φ(X,W̃ ) = 1)
= vaβT cov(x¯f+ − x¯f−)β + var(¯f+ − ¯f− ∣φ(X,W̃ ) = 1)
= vaβT cov(x¯f+ − x¯f−)β + var(¯f+ − ¯f−)
The second equality is a result of Theorem 3. By assumption n is large enough that x¯f+−x¯f−
and ¯f+ − ¯f− are normally distributed, and thus orthogonality implies independence. Thus,
rerandomization does not affect the variance of ¯f+ − ¯f− , and the final equality holds. The
remainder of the proof is analogous to Morgan and Rubin (2012), because it is identical to
the treatment-versus-control case, as in the proof of Theorem 3. ◻
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